Measurement of ras p21 in the urine of patients with urological tumours.

Abstract excerpt

We have measured the product of the ras oncogene, ras p21, in random un-timed urine samples using an immunoblotting method which relies upon enhanced chemiluminescence for visualisation of the nitrocellulose filter. Urine samples were analysed from groups of patients with prostate (n = 10) or bladder (n = 25) cancer and a control group (n = 30) with no apparent urological disease. The mean concentration of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Prostatic Neoplasms
• Share to Proto-Oncogene Proteins p21(ras)